CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
November 2021—Thermo Fisher Scientific has updated its research use only Applied Biosystems TaqMan SARS-CoV-2 Mutation Panel to include the mu strain. Laboratories can build their own panel from a menu of more than 50 verified real-time PCR assays that allows the user to identify relevant SARS-CoV-2 mutations and adapt as additional mutations and variants emerge.
The panel combines the company’s TaqMan SNP genotyping assays with a one-step RT-PCR reaction. Results are available in about an hour.
Pages: 1 2